0001209191-22-021458.txt : 20220329
0001209191-22-021458.hdr.sgml : 20220329
20220329161502
ACCESSION NUMBER: 0001209191-22-021458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220209
FILED AS OF DATE: 20220329
DATE AS OF CHANGE: 20220329
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Suri Anish
CENTRAL INDEX KEY: 0001739130
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 22780939
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-09
0
0001645460
Cue Biopharma, Inc.
CUE
0001739130
Suri Anish
C/O CUE BIOPHARMA, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
0
1
0
0
PRESIDENT AND CSO
Stock Option (right to buy)
6.91
2022-02-09
4
A
0
82000
0.00
A
2032-02-08
Common Stock
82000
82000
D
Stock Option (right to buy)
5.01
2022-03-25
4
A
0
21333
0.00
A
2032-03-24
Common Stock
21333
21333
D
1. This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 9, 2022.
2. This stock option grant becomes exercisable in eight equal semi-annual installments beginning September 25, 2022.
/s/ Anish Suri by Colin Sandercock,
attorney-in-fact
2022-03-29